Gershanik OS - Search Results

1

Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides.

Dziewczapolski G, Menalled LB, García MC, Mora MA, Gershanik OS, Rubinstein M. Dziewczapolski G, et al. Among authors: gershanik os. Neuroreport. 1998 Jan 5;9(1):1-5. doi: 10.1097/00001756-199801050-00001. Neuroreport. 1998. PMID: 9592037

2

Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats.

Dziewczapolski G, Murer G, Agid Y, Gershanik O, Raisman-Vozari R. Dziewczapolski G, et al. Neuroreport. 1997 Mar 3;8(4):975-9. doi: 10.1097/00001756-199703030-00031. Neuroreport. 1997. PMID: 9141075

3

Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine.

Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK. Rubinstein M, et al. Cell. 1997 Sep 19;90(6):991-1001. doi: 10.1016/s0092-8674(00)80365-7. Cell. 1997. PMID: 9323127

4

Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon.

Dziewczapolski G, Menalled LB, Savino MT, Mora M, Stefano FJ, Gershanik O. Dziewczapolski G, et al. Mov Disord. 1997 Mar;12(2):159-66. doi: 10.1002/mds.870120205. Mov Disord. 1997. PMID: 9087973

5

Postsynaptic bimodal effect of sulpiride on locomotor activity induced by pergolide in catecholamine-depleted mice.

Rubinstein M, Gershanik O, Stefano FJ. Rubinstein M, et al. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):115-7. doi: 10.1007/BF00169487. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3368011

6

Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.

Rubinstein M, Gershanik O, Stefano FJ. Rubinstein M, et al. Eur J Pharmacol. 1988 Apr 13;148(3):419-26. doi: 10.1016/0014-2999(88)90121-5. Eur J Pharmacol. 1988. PMID: 2968273

7

Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.

Rubinstein M, Muschietti JP, Gershanik O, Flawia MM, Stefano FJ. Rubinstein M, et al. J Pharmacol Exp Ther. 1990 Feb;252(2):810-6. J Pharmacol Exp Ther. 1990. PMID: 2138223

8

Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.

Rubinstein M, Schinder AF, Gershanik O, Stefano FJ. Rubinstein M, et al. Life Sci. 1989;44(5):337-46. doi: 10.1016/0024-3205(89)90227-0. Life Sci. 1989. PMID: 2536881

9

Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging.

Delfino M, Kalisch R, Czisch M, Larramendy C, Ricatti J, Taravini IR, Trenkwalder C, Murer MG, Auer DP, Gershanik OS. Delfino M, et al. Among authors: gershanik os. Neuropsychopharmacology. 2007 Sep;32(9):1911-21. doi: 10.1038/sj.npp.1301329. Epub 2007 Feb 7. Neuropsychopharmacology. 2007. PMID: 17287822

10

Effects of orally administered levodopa on mesencephalic dopaminergic neurons undergoing a degenerative process.

Ferrario JE, Delfino MA, Stefano AV, Zbarsky V, Douhou A, Murer MG, Raisman-Vozari R, Gershanik OS. Ferrario JE, et al. Among authors: gershanik os. Neurosci Res. 2003 Dec;47(4):431-6. doi: 10.1016/j.neures.2003.08.001. Neurosci Res. 2003. PMID: 14630347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results